526887662	526887662	CD	B-NP	O
|	|	NN	I-NP	O
MMC	MMC	NN	I-NP	O
|	|	NN	I-NP	O
64854464	64854464	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8431527	8431527	CD	B-NP	O
|	|	CC	I-NP	O
8/10/2004	8/10/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Ventricular	Ventricular	JJ	I-NP	I-protein
tachycardia	tachycardia	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
ICD	ICD	NN	I-NP	I-protein
placement	placement	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/25/2004	9/25/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/1/2004	8/1/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MOSCHETTI	MOSCHETTI	NN	B-NP	O
,	,	,	O	O
SCOT	SCOT	NN	B-NP	O
523-84-87-2	523-84-87-2	CD	I-NP	O
Ine	Ine	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/23/04	10/23/04	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MODIN	MODIN	NNP	B-NP	O
,	,	,	O	O
GARRET	GARRET	NNP	B-NP	O
LEONEL	LEONEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	B-protein
400	400	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/22	1/22	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/04	10/22/04	CD	B-NP	O
by	by	IN	B-PP	O
SWINDLER	SWINDLER	NN	B-NP	O
,	,	,	O	O
WILL	WILL	MD	O	O
A	A	DT	O	O
MOHAMMED	MOHAMMED	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
94896940	94896940	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/04	10/22/04	CD	B-NP	O
by	by	IN	B-PP	O
RUEGSEGGER	RUEGSEGGER	NN	B-NP	O
,	,	,	O	O
ELIJAH	ELIJAH	NNP	B-NP	O
J	J	NNP	I-NP	O
BERNARDO	BERNARDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
94896940	94896940	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
DILANTIN	DILANTIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PHENYTOIN	PHENYTOIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
If	If	IN	B-ADJP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/04	10/22/04	CD	B-NP	O
by	by	IN	B-PP	O
WONDRA	WONDRA	NNP	B-NP	O
,	,	,	O	O
SONNY	SONNY	NNP	B-NP	O
R	R	NNP	I-NP	O
CHANCE	CHANCE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
94896940	94896940	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/22	1/22	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
switching	switch	VBG	B-VP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
po	po	NN	I-NP	O
qhs	qh	VBZ	B-VP	O
Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/04	10/22/04	CD	B-NP	O
by	by	IN	B-PP	O
DEPAOLI	DEPAOLI	NNP	B-NP	O
,	,	,	O	O
RUDOLPH	RUDOLPH	NNP	B-NP	O
D	D	NNP	I-NP	O
RENALDO	RENALDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
KEFLEX	KEFLEX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
CEPHALEXIN	CEPHALEXIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
250	250	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QID	QID	NN	I-NP	O
X	X	SYM	B-NP	O
10	10	CD	B-NP	O
doses	dose	NNS	I-NP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
LISINOPRIL	LISINOPRIL	NN	I-NP	O
20	20	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/23/04	10/23/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

200	200	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PRILOSEC	PRILOSEC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Colp	Colp	NNP	I-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	I-NP	O
40	40	CD	I-NP	O
am	am	NN	I-NP	O
5/25/04	5/25/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Chesley	Chesley	NNP	I-NP	O
,	,	,	O	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Winger	Winger	NNP	I-NP	O
to	to	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
pending	pende	VBG	B-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/30/2004	7/30/2004	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Hoobler	Hoobler	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Ventricular	Ventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Ventricular	Ventricular	NNP	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ICD	ICD	NN	I-NP	O
placement	placement	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
h/o	h/o	NNP	I-NP	O
Right	Right	NNP	I-NP	O
occipital	occipital	JJ	I-NP	O
parietal	parietal	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
,	,	,	O	O
CV	CV	NN	B-NP	O
,	,	,	O	O
Hypertension	Hypertension	NNP	B-NP	O
Seizure	Seizure	NNP	I-NP	O
d/o	d/o	NN	I-NP	O
,	,	,	O	O
afib/flutter	afib/flutter	RB	B-ADVP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
DM	DM	NN	I-NP	O
-	-	HYPH	B-NP	O
diet	diet	NN	I-NP	O
controlled	control	VBN	B-VP	O
OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
ICD	ICD	NN	B-NP	O
placement	placement	NN	I-NP	O
3/16/2004	3/16/2004	CD	I-NP	O
Left	Left	NN	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
yo	yo	NN	I-NP	O
w/CHF	w/CHF	NN	I-NP	O
presenting	present	VBG	B-VP	O
w/episode	w/episode	NN	B-NP	O
of	of	IN	B-PP	O
Vtach	Vtach	NN	B-NP	O
at	at	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

felt	feel	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
nauseous	nauseous	JJ	I-ADJP	O
on	on	IN	B-PP	O
coming	come	VBG	B-VP	O
home	home	NN	B-ADVP	O
from	from	IN	B-PP	O
work	work	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
PTA	PTA	NN	I-NP	O
.	.	.	O	O

Wife	Wife	NNP	B-NP	O
noticed	notice	VBD	B-VP	O
pallor	pallor	NN	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
came	come	VBD	B-VP	O
home	home	NN	B-NP	O
,	,	,	O	O
called	call	VBN	B-VP	O
ambulance	ambulance	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
monomorphic	monomorphic	JJ	B-NP	O
Vtach	Vtach	NN	I-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
which	which	WDT	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
lidocaine	lidocaine	NN	B-NP	O
.	.	.	O	O

Lidocaine	Lidocaine	NN	B-NP	O
drip	drip	NN	I-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	VBN	B-VP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
of	of	IN	B-PP	O
transfer	transfer	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
abscene	abscene	NN	I-NP	O
of	of	IN	B-PP	O
further	further	JJ	B-NP	O
VT.	VT.	NNP	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
troponin	troponin	NN	B-NP	O
of	of	IN	B-PP	O
0.8	0.8	CD	B-NP	O
at	at	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	B-ADJP	O
unclear	unclear	JJ	I-ADJP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
event	event	NN	I-NP	O
which	which	WDT	B-NP	O
caused	cause	VBD	B-VP	O
VT	VT	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
VT	VT	NN	I-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
bump	bump	NN	I-NP	O
in	in	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
anginal	anginal	JJ	B-NP	B-protein
equivalent	equivalent	JJ	I-NP	I-protein
w/jaw	w/jaw	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
which	which	WDT	B-NP	O
worsens	worsen	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
carries	carry	VBZ	B-VP	O
heavy	heavy	JJ	B-NP	O
things	thing	NNS	I-NP	O
or	or	CC	O	O
walks	walk	VBZ	B-VP	O
up	up	RP	B-PRT	O
flights	flight	NNS	B-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
outside	outside	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
15-20	15-20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
global	global	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
onadmission	onadmission	NN	I-NP	O
w/JVP	w/JVP	NN	I-NP	O
10	10	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
faint	faint	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
SEM	SEM	NNP	I-NP	O
worse	worse	JJR	B-NP	O
w/inc	w/inc	NN	I-NP	O
.	.	.	O	O

afterload	afterload	RB	B-ADVP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
11/1	11/1	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
vtach	vtach	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
bump	bump	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
was	be	VBD	B-VP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
slowly	slowly	RB	B-ADVP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
worsening	worsen	VBG	I-VP	O
HTN	HTN	NN	B-NP	B-protein
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
along	along	IN	B-PP	O
w/a	w/a	NN	B-NP	O
prolonged	prolong	VBD	B-VP	O
episode	episode	NN	B-NP	O
of	of	IN	B-PP	O
vtach	vtach	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
by	by	IN	B-PP	O
approximately	approximately	RB	B-NP	O
5	5	CD	I-NP	O
L	L	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
loaded	load	VBN	I-VP	O
w/amiodarone	w/amiodarone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
weight	weight	NN	I-NP	O
also	also	RB	B-ADVP	O
dropped	drop	VBD	B-VP	O
5	5	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
and	and	CC	O	O
revealed	reveal	VBD	B-VP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
discrete	discrete	JJ	I-NP	O
rt	rt	NN	I-NP	O
PDA	PDA	NN	I-NP	O
lesion	lesion	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
D1	D1	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADJP	O
essentially	essentially	RB	I-ADJP	O
clean	clean	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
interventions	intervention	NNS	I-NP	O
were	be	VBD	B-VP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
PCWP	PCWP	NN	I-NP	B-protein
of	of	IN	B-PP	O
6	6	CD	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
vtach	vtach	NN	I-NP	O
episodes	episode	NNS	I-NP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
400	400	CD	B-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
of	of	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
3/16/2004	3/16/2004	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
initial	initial	JJ	I-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
his	his	PRP$	B-NP	O
aflutter	aflutter	NN	I-NP	O
ablated	ablate	VBN	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
the	the	DT	B-NP	O
propensity	propensity	NN	I-NP	O
for	for	IN	B-PP	O
vtach	vtach	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
lt	lt	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
clot	clot	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
during	during	IN	B-PP	O
TEE	TEE	NN	B-NP	O
,	,	,	O	O
so	so	RB	O	O
rhythm	rhythm	JJ	B-NP	O
ablation	ablation	NN	I-NP	O
was	be	VBD	B-VP	O
deferred	defer	VBN	I-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
transthroracic	transthroracic	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
performed	perform	VBN	I-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
w/anterior	w/anterior	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
and	and	CC	O	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
broad	broad	JJ	I-NP	O
differential	differential	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
was	be	VBD	B-VP	O
entertained	entertain	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-NP	O
no	no	DT	I-NP	O
conclusive	conclusive	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
P	P	NN	I-NP	B-DNA
CP	CP	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
appointments	appointment	NNS	I-NP	O
were	be	VBD	B-VP	O
coordinated	coordinate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
attending	attend	VBG	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Versteegh	Versteegh	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
w/Dr	w/Dr	NN	B-NP	O
.	.	.	O	O

Yafuso	Yafuso	NN	B-NP	O
as	as	IN	B-PP	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
section	section	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
take	take	VB	I-VP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
three	three	CD	I-NP	O
nights	night	NNS	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
subsequently	subsequently	RB	I-VP	O
drop	drop	VB	I-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
unless	unless	IN	B-SBAR	O
differently	differently	RB	B-ADVP	O
as	as	IN	B-SBAR	O
suggested	suggest	VBN	B-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
which	which	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
,	,	,	O	O
May	May	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Wed	Wed	VBD	B-VP	O
September	September	NNP	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
VNA	VNA	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
an	an	DT	B-NP	O
MD	MD	NN	I-NP	O
immediately	immediately	RB	B-NP	O
w/chest	w/ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
sob	sob	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
pallor	pallor	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-ADJP	O
adjusted	adjust	VBN	I-ADJP	O
to	to	TO	B-PP	O
maximum	maximum	JJ	B-NP	O
doses	dose	NNS	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
under	under	IN	B-PP	O
close	close	JJ	B-NP	O
acute	acute	JJ	I-NP	O
care	care	NN	I-NP	O
monitoring	monitor	VBG	B-VP	O
to	to	TO	I-VP	O
facilitate	facilitate	VB	I-VP	O
optimization	optimization	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
outpt	outpt	JJ	I-NP	O
regimens	regimen	NNS	I-NP	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
changes	change	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
discretion	discretion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
PCP	PCP	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Schwarm	Schwarm	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
presented	present	VBD	B-VP	O
w/an	w/an	JJ	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
which	which	WDT	B-NP	O
slowly	slowly	RB	B-ADVP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
levels	level	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
hypoperfusion	hypoperfusion	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
vtach	vtach	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
dye	dye	NN	B-NP	O
load	load	NN	I-NP	O
from	from	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
F/u	F/u	NN	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
.	.	.	O	O

Stop	Stop	VB	B-VP	O
old	old	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
only	only	JJ	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
from	from	IN	B-PP	O
here	here	RB	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TEFFETELLER	TEFFETELLER	NN	B-NP	O
,	,	,	O	O
HOSEA	HOSEA	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DX313	DX313	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/23/04	10/23/04	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
34	34	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

